MASTORINO, LUCA
MASTORINO, LUCA
SCIENZE MEDICHE
"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors
2022-01-01 Mastorino, Luca; Susca, Sara; Cariti, Caterina; Verrone, Anna; Stroppiana, Elena; Ortoncelli, Michela; Dapavo, Paolo; Ribero, Simone; Quaglino, Pietro
593 Inverse psoriasis involvement in moderate to severe psoriatic patients: A comparison between anti IL23 and anti IL17
2023-01-01 Mastorino, L.; Macagno, N.; Dapavo, P.; Ribero, S.; Quaglino, P.
A Multicentre, Randomised Clinical Trial to Compare a Topical Nitrizinc® Complex Solution Versus Cryotherapy for the Treatment of Anogenital Warts
2020-01-01 Pontini, Paolo; Mastorino, Luca; Gaspari, Valeria; Granger, Corinne; Ramoni, Stefano; Delmonte, Sergio; Evangelista, Valeria; Cusini, Marco
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era
2021-01-01 Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
2022-01-01 Rubatto, Marco; Merli, Martina; Avallone, Gianluca; Agostini, Andrea; Mastorino, Luca; Caliendo, Virginia; Barcellini, Amelia; Vitolo, Viviana; Valvo, Francesca; Fierro, Maria Teresa; Ribero, Simone; Quaglino, Pietro
Alopecia areata after COVID-19 vaccination
2022-01-01 Gallo G.; Mastorino L.; Tonella L.; Ribero S.; Quaglino P.
Are serious ophthalmic adverse events on dupilumab treatment for atopic dermatitis dose related?
2021-01-01 Mastorino L.; Ortoncelli M.; Avallone G.; Quaglino P.; Ribero S.
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study
2022-01-01 Avallone G.; Roccuzzo G.; Torres-Navarro I.; Gelato F.; Mastorino L.; Agostini A.; Merli M.; Cavallo F.; Rubatto M.; Senetta R.; Botella Estrada R.; Ribero S.; Quaglino P.
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden?
2021-01-01 Mastorino L.; Dapavo P.; Avallone G.; Merli M.; Cariti C.; Rubatto M.; Pala V.; Quaglino P.; Ribero S.
Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks
2022-01-01 Mastorino, Luca; Cariti, C; Susca, S; Boskovic, S; Aquino, C; Ortoncelli, M; Stroppiana, E; Verrone, A; Dapavo, P; Quaglino, P; Ribero, Simone
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma
2021-01-01 Avallone, Gianluca; Trunfio, Mattia; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; Caracciolo, Daniele; Calcagno, Andrea; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro; Ribero, Simone
Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients
2022-01-01 Mastorino, Luca; Rosset, François; Gelato, Federica; Ortoncelli, Michela; Cavaliere, Giovanni; Quaglino, Pietro; Ribero, Simone
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer
2022-01-01 Rubatto, Marco; Sciamarrelli, Nadia; Borriello, Silvia; Pala, Valentina; Mastorino, Luca; Tonella, Luca; Ribero, Simone; Quaglino, Pietro
Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patients
2021-01-01 Cariti, C; Dapavo, P; Mastorino, L; Ortoncelli, M; Siliquini, N; Merli, M; Avallone, G; Giordano, S; Fabrizio, R; Susca, S; Verrone, A; Stroppiana, E; Quaglino, P; Ribero, S
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma
2022-01-01 Nepote A.; Avallone G.; Ribero S.; Cavallo F.; Roccuzzo G.; Mastorino L.; Conforti C.; Paruzzo L.; Poletto S.; Schianca F.C.; Quaglino P.; Aglietta M.
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study
2022-01-01 Gullo G.; Rubatto M.; Fava P.; Brizio M.; Tonella L.; Ribero S.; Medri M.; Avallone G.; Mastorino L.; Fierro M.T.; Stanganelli I.; Quaglino P.
Dose reduction of dupilumab in atopic patients with controlled atopic dermatitis: A safe and effective practice?
2023-01-01 Mastorino, Luca; Gelato, Federica; Richiardi, Irene; Cavaliere, Giovanni; Quaglino, Pietro; Ortoncelli, Michela; Ribero, Simone
Dramatic response of face desmoplastic melanoma after two doses of immunotherapy
2023-01-01 Rubatto, Marco; Gelato, Federica; Broganelli, Paolo; Fava, Paolo; Senetta, Rebecca; Avallone, Gianluca; Mastorino, Luca; Grandinetti, Damiano; Ribero, Simone; Quaglino, Pietro
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents
2022-01-01 Roccuzzo, Gabriele; Mastorino, Luca; Susca, Sara; Cariti, Caterina; Passerini, Stefania G; Sciamarrelli, Nadia; Borriello, Silvia; Macagno, Nicole; Sliquini, Niccolò; Avallone, Gianluca; Verrone, Anna; Stroppiana, Elena; Quaglino, Pietro; Ortoncelli, Michela; Dapavo, Paolo; Ribero, Simone
Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study
2023-01-01 Repetto, Federica; Roccuzzo, Gabriele; Burzi, Lorenza; Mastorino, Luca; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors | 2022 | Mastorino, Luca; Susca, Sara; Cariti, Caterina; Verrone, Anna; Stroppiana, Elena; Ortoncelli, Michela; Dapavo, Paolo; Ribero, Simone; Quaglino, Pietro | |
593 Inverse psoriasis involvement in moderate to severe psoriatic patients: A comparison between anti IL23 and anti IL17 | 2023 | Mastorino, L.; Macagno, N.; Dapavo, P.; Ribero, S.; Quaglino, P. | |
A Multicentre, Randomised Clinical Trial to Compare a Topical Nitrizinc® Complex Solution Versus Cryotherapy for the Treatment of Anogenital Warts | 2020 | Pontini, Paolo; Mastorino, Luca; Gaspari, Valeria; Granger, Corinne; Ramoni, Stefano; Delmonte, Sergio; Evangelista, Valeria; Cusini, Marco | |
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era | 2021 | Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone | |
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review | 2022 | Rubatto, Marco; Merli, Martina; Avallone, Gianluca; Agostini, Andrea; Mastorino, Luca; Caliendo, Virginia; Barcellini, Amelia; Vitolo, Viviana; Valvo, Francesca; Fierro, Maria Teresa; Ribero, Simone; Quaglino, Pietro | |
Alopecia areata after COVID-19 vaccination | 2022 | Gallo G.; Mastorino L.; Tonella L.; Ribero S.; Quaglino P. | |
Are serious ophthalmic adverse events on dupilumab treatment for atopic dermatitis dose related? | 2021 | Mastorino L.; Ortoncelli M.; Avallone G.; Quaglino P.; Ribero S. | |
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study | 2022 | Avallone G.; Roccuzzo G.; Torres-Navarro I.; Gelato F.; Mastorino L.; Agostini A.; Merli M.; Cavallo F.; Rubatto M.; Senetta R.; Botella Estrada R.; Ribero S.; Quaglino P. | |
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden? | 2021 | Mastorino L.; Dapavo P.; Avallone G.; Merli M.; Cariti C.; Rubatto M.; Pala V.; Quaglino P.; Ribero S. | |
Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks | 2022 | Mastorino, Luca; Cariti, C; Susca, S; Boskovic, S; Aquino, C; Ortoncelli, M; Stroppiana, E; Verrone, A; Dapavo, P; Quaglino, P; Ribero, Simone | |
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma | 2021 | Avallone, Gianluca; Trunfio, Mattia; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; Caracciolo, Daniele; Calcagno, Andrea; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro; Ribero, Simone | |
Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients | 2022 | Mastorino, Luca; Rosset, François; Gelato, Federica; Ortoncelli, Michela; Cavaliere, Giovanni; Quaglino, Pietro; Ribero, Simone | |
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer | 2022 | Rubatto, Marco; Sciamarrelli, Nadia; Borriello, Silvia; Pala, Valentina; Mastorino, Luca; Tonella, Luca; Ribero, Simone; Quaglino, Pietro | |
Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patients | 2021 | Cariti, C; Dapavo, P; Mastorino, L; Ortoncelli, M; Siliquini, N; Merli, M; Avallone, G; Giordano, S; Fabrizio, R; Susca, S; Verrone, A; Stroppiana, E; Quaglino, P; Ribero, S | |
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma | 2022 | Nepote A.; Avallone G.; Ribero S.; Cavallo F.; Roccuzzo G.; Mastorino L.; Conforti C.; Paruzzo L.; Poletto S.; Schianca F.C.; Quaglino P.; Aglietta M. | |
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study | 2022 | Gullo G.; Rubatto M.; Fava P.; Brizio M.; Tonella L.; Ribero S.; Medri M.; Avallone G.; Mastorino L.; Fierro M.T.; Stanganelli I.; Quaglino P. | |
Dose reduction of dupilumab in atopic patients with controlled atopic dermatitis: A safe and effective practice? | 2023 | Mastorino, Luca; Gelato, Federica; Richiardi, Irene; Cavaliere, Giovanni; Quaglino, Pietro; Ortoncelli, Michela; Ribero, Simone | |
Dramatic response of face desmoplastic melanoma after two doses of immunotherapy | 2023 | Rubatto, Marco; Gelato, Federica; Broganelli, Paolo; Fava, Paolo; Senetta, Rebecca; Avallone, Gianluca; Mastorino, Luca; Grandinetti, Damiano; Ribero, Simone; Quaglino, Pietro | |
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents | 2022 | Roccuzzo, Gabriele; Mastorino, Luca; Susca, Sara; Cariti, Caterina; Passerini, Stefania G; Sciamarrelli, Nadia; Borriello, Silvia; Macagno, Nicole; Sliquini, Niccolò; Avallone, Gianluca; Verrone, Anna; Stroppiana, Elena; Quaglino, Pietro; Ortoncelli, Michela; Dapavo, Paolo; Ribero, Simone | |
Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study | 2023 | Repetto, Federica; Roccuzzo, Gabriele; Burzi, Lorenza; Mastorino, Luca; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone |